-
The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management
Elizabeth A Lancet, Janet T Holbrook, Robert A Wise & Nicola A Hanania
Research Update: Clinical Investigation
-
The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management
Elizabeth A Lancet, Janet T Holbrook, Robert A Wise & Nicola A Hanania
Research Update: Clinical Investigation
-
The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management
Elizabeth A Lancet, Janet T Holbrook, Robert A Wise & Nicola A Hanania
Research Update: Clinical Investigation
-
The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management
Elizabeth A Lancet, Janet T Holbrook, Robert A Wise & Nicola A Hanania
Research Update: Clinical Investigation
-
The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management
Elizabeth A Lancet, Janet T Holbrook, Robert A Wise & Nicola A Hanania
Research Update: Clinical Investigation
-
The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management
Elizabeth A Lancet, Janet T Holbrook, Robert A Wise & Nicola A Hanania
Research Update: Clinical Investigation
-
The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management
Elizabeth A Lancet, Janet T Holbrook, Robert A Wise & Nicola A Hanania
Research Update: Clinical Investigation
-
The American Lung Association: Asthma Clinical Research Centers network: addressing real life questions in asthma management
Elizabeth A Lancet, Janet T Holbrook, Robert A Wise & Nicola A Hanania
Research Update: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Treatment of heparin-induced thrombocytopenia: what are the contributions of clinical trials?
Moonjung Jung, Lawrence Rice
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Novel treatments of interstitial cystitis/bladder pain syndrome based on pathophysiology
Hann-Chorng Kuo
Review: Clinical Trail Outcomes: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Src tyrosine kinase inhibitors in the treatment of lung cancer: rationale and clinical data
Sacha I Rothschild,Oliver Gautschi
Therapeutic Perspective: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation